| 000 | 01386 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513222250.0 | ||
| 264 | 0 | _c20001025 | |
| 008 | 200010s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeiner, H L | |
| 245 | 0 | 0 |
_aNasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cOct 2000 |
||
| 300 |
_a567-79 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aAmyloid _xanalysis |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xadministration & dosage |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aBrain Chemistry |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMice |
| 700 | 1 | _aLemere, C A | |
| 700 | 1 | _aMaron, R | |
| 700 | 1 | _aSpooner, E T | |
| 700 | 1 | _aGrenfell, T J | |
| 700 | 1 | _aMori, C | |
| 700 | 1 | _aIssazadeh, S | |
| 700 | 1 | _aHancock, W W | |
| 700 | 1 | _aSelkoe, D J | |
| 773 | 0 |
_tAnnals of neurology _gvol. 48 _gno. 4 _gp. 567-79 |
|
| 999 |
_c10971573 _d10971573 |
||